title: Biomarkers and response to bevacizumab--letter.
authors.affiliation: Authors' Affiliations: Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana; Division of Pharmacology, Department of Clinical and Experimental Medicine; Division of Medical Oncology, Department of Translational Research, University of Pisa, Pisa; and Istituto Toscano Tumori, Firenze, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Cremolini
authors.forename: Fotios
authors.initials: F
authors.lastname: Loupakis
authors.forename: Guido
authors.initials: G
authors.lastname: Bocci
authors.forename: Alfredo
authors.initials: A
authors.lastname: Falcone
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D005185:Fallopian Tube Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood*; D018579:Patient Selection; D010534:Peritoneal Neoplasms / Q000097:blood*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor